The development of minimally invasive cardiac patches, either as hemostatic dressing or
treating myocardial infarction, is of clinical significance but remains a major challenge …

Myocardial infarction is one of the more common cardiovascular diseases, and remains the
leading cause of death, globally. Hydrogels (namely, those using natural polymers) provide …

Myocardial infarction (MI) is a major disease posing a significant threat to human health, as it
leads to necrosis of numerous cardiomyocytes (CMs), left ventricle dilation, and cardiac …

Cardiac failure is a critical condition that results in life-threatening consequences. Due to a
limited number of organ donors, tissue engineering has emerged to generate functional …

Ischemic heart disease is the most common type of heart disease, responsible for roughly 10
million deaths worldwide annually. While standard clinical interventions have resulted in …

Injectable biopolymer hydrogels have gained attention for use as scaffolds to promote
cardiac function and prevent negative left ventricular (LV) remodeling post-myocardial …

Heart failure is a major international health issue. Myocardial mass loss and lack of
contractility are precursors to heart failure. Surgical demand for effective myocardial repair is …

The limited regenerative capacity of the heart after a myocardial infarct results in remodeling
processes that can progress to congestive heart failure (CHF). Several strategies including …

Hydrogels are three-dimensional hydrophilic polymeric networks that can be made from a
wide range of natural and synthetic polymers. This review discusses recent advanced …

Cardiac tissue regeneration is an integrated process involving both cells and supporting
matrix. Cardiomyocytes and stem cells are utilized to regenerate cardiac tissue. Hydrogels …